Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Context Safe and effective strategies to curb rising obesity prevalence rates are urgently needed and medications may play a more prominent role in future therapeutic regimens. Objective To review systematically the long-term efficacy and safety of approved antiobesity medications. Data sources MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Current Science Meta-register of Controlled Trials, and reference lists of original studies and reviews were searched. Drug manufacturers and two obesity experts were contacted. No language restrictions were imposed. Study selection Double-blind, randomized controlled studies of approved antiobesity medications with follow-up periods of 1 y or greater were eligible for inclusion. Data extraction Two reviewers independently assessed all potentially relevant studies for inclusion and methodological quality using standardized abstraction forms. Results A total of 11orlistat (n=6021) and three sibutramine (n=929) studies met inclusion criteria. Attrition rates averaged 33% in orlistat studies and 48% in sibutramine studies. A random effects model was used for meta-analysis. Compared to placebo, orlistat-treated patients displayed a 2.7 kg (95% CI: 2.3-3.1 kg) or 2.9% (95% CI: 2.3-3.4%) greater reduction in weight and patients on sibutramine displayed a 4.3 kg (95% CI: 3.6-4.9 kg) or 4.6% (95% CI: 3.8-5.4%) greater weight reduction after 1 y of follow-up. The number of patients achieving 10% or greater weight loss was 12% (95% CI: 8-…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pancreatic lipase inhibitor, orlistat blocks dietary fat absorption, resulting in ~3–5% weight loss.”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [57]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Cited by
Items 201–300 of 351
Neuropeptide Y receptors as targets of obesity treatment
PhD, A. I., PhD, M. M., MacNeil, D. J., PhD, T. F., & PhD, A. K. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.12.1701 · Cited by 10
Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease
Miller, W. M., Janosz, K. E. N., Yanez, J., & McCullough, P. A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.4.743 · Cited by 10
Fabbrini, E., & Klein, S. (2008) · Clinical Cornerstone · doi:10.1016/s1098-3597(08)60027-7 · Cited by 9
Auti, P. S., Jagetiya, S., & Paul, A. T. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136257 · Cited by 9
How do chain lengths of acyl-l-carnitines affect their surface adsorption and solution aggregation?
Liu, H., Fa, K., Hu, X., Li, Z., Ma, K., Liao, M., Zhang, L., Schweins, R., Maestro, A., Li, P., et al. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.11.056 · Cited by 10
Challenges for Causal Inference in Obesity Research
Auld, M. C., & Grootendorst, P. V. (2011) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199736362.013.0014 · Cited by 13
Sibutramine & naloxone: Infra-additive interaction in the regulation of appetite?
Tallett, A. J., Blundell, J. E., & Rodgers, R. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.004 · Cited by 9
Chigutsa, E., Her, L., Ma, X., Urva, S., & Schneck, K. B. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3750 · Cited by 11
He, R., Shi, Y., Lu, X., Zhou, Y., Liu, Z., Zhang, Z., & Liu, A. (2024) · Plant Foods for Human Nutrition · doi:10.1007/s11130-024-01229-z · Cited by 8
Diagnostic definitions — metabolic syndrome
Day, C. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050030101 · Cited by 8
Medical treatment of obesity: Modern approaches and prospects
Titova, V. V., Омариевна, У. Ф., & Demidova, T. Y. (2024) · FOCUS Endocrinology · doi:10.62751/2713-0177-2024-5-4-18 · Cited by 8
The effect ofSargassum confusumon reduction of body fat in obese women
Min, K. S., Han, D., Kwon, S., Yeo, K.-M., Kim, B.-N., & Ly, S. Y. (2014) · Journal of Nutrition and Health · doi:10.4163/jnh.2014.47.1.23 · Cited by 8
Phytochemical Profile and Anti-lipase Activity of Balkan Endemic Jurinea tzar-ferdinandii
Trendafilova, A. B., Todorova, M. N., Kutova, N., & Guncheva, M. (2018) · Natural Product Communications · doi:10.1177/1934578x1801300823 · Cited by 7
Weight management with orlistat in type 2 diabetes: an electronic health records study
Ghosal, S., Heron, N., Mason, K. J., Bailey, J., & Jordan, K. P. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0684 · Cited by 7
Chaichanavichkij, P., Hartmann, M., Scott, S. M., Fenton, N., Knowles, C. H., Disorders of Defaecation Delphi Group, Carrington, E. V., Chew, C., Curry, A., Gorissen, K. J., et al. (2023) · Techniques in Coloproctology · doi:10.1007/s10151-023-02843-w · Cited by 8
Some ethical reflections on weight-loss diets
Ertin, H., & Özaltay, B. (2011) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1012-1344 · Cited by 9
Effects of Sibutramine on Gastric Emptying, Intestinal Motility and Rectal Tone in Dogs
Xu, J., & Chen, J. D. Z. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9837-x · Cited by 6
Tuah, N. A., Qureshi, S., Dhillo, W. S., & Majeed, A. (2010) · Primary Health Care Research & Development · doi:10.1017/s1463423610000289 · Cited by 6
Pasado, presente y futuro de la farmacoterapia para la obesidad
Benaiges, D., Pedro‐Botet, J., Roux, J. A. F., Climent, E., & Goday, A. (2017) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2017.06.002 · Cited by 9
One Pill Makes you Smaller: The Demand for Anti-Obesity Drugs
Cawley, J., & Rizzo, J. A. (2006) · Advances in health economics and health services research · doi:10.1016/s0731-2199(06)17007-7 · Cited by 7
Gaining weight after taking orlistat: A qualitative study of patients at 18-months follow-up
Hollywood, A., & Ogden, J. (2014) · Journal of Health Psychology · doi:10.1177/1359105314532153 · Cited by 7
Ballantyne, C. M. (2007) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e318053d190 · Cited by 6
Efficient and reliable screening of anti‐obesity agents on a micro‐cell pattern chip
Kim, G. Y., Jeong, H., Yeom, S., Lee, C., & Roh, C. (2015) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.4876 · Cited by 6
Currents in Contemporary Ethics
Hinds, H. L. (2005) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2005.tb00522.x · Cited by 6
Abolhassani, A., Moghadasian, M. H., Sedaghatnezhad, N., & Jafarnejad, S. (2025) · Heart and Mind · doi:10.4103/hm.hm-d-24-00161 · Cited by 5
Patil, S., Patil, M. R., Maheshwari, V. L., & Patil, R. H. (2022) · Springer eBooks · doi:10.1007/978-981-19-0932-0_7 · Cited by 7
Therapeutics in Metabolic Diseases
Natesan, V. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_17 · Cited by 5
From root to Recovery: The role of herbs in polycystic ovary syndrome management
Zafar, N.-U.-A., Qureshi, R., Siddiqa, A., Naqvi, S. A. M., Waheed, F., Mashwani, Z., Ali, A., Ramírez, K. A. H., Medina‐Pérez, G., Peláez-Acero, A., et al. (2025) · Steroids · doi:10.1016/j.steroids.2025.109606 · Cited by 6
van Genugten, L. (2012) · Cited by 5
Sharman, M. J., Jose, K., Venn, A., Banks, S., Ayton, J. E., & Cleland, V. J. (2019) · BMC Obesity · doi:10.1186/s40608-019-0239-3 · Cited by 5
Shukla, A. P., & Mandel, L. (2018) · Springer eBooks · doi:10.1007/978-3-030-01039-3_4 · Cited by 8
Management of Obesity: Pharmacotherapy
Atkinson, R. L. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch25 · Cited by 5
Gastric Applications of Electrical Field Stimulation
Hogan, A. M., Gallagher, T. K., Kennelly, R., Baird, A. W., & Winter, D. C. (2009) · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0b013e31819797b4 · Cited by 6
Stéatopathie métabolique : prise en charge
Pariente, A. E. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.02.028 · Cited by 8
Past, present and future of pharmacotherapy for obesity
Benaiges, D., Pedro‐Botet, J., Roux, J. A. F., Climent, E., & Goday, A. (2017) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2017.06.003 · Cited by 7
Overweight and obesity - use of portion control in management.
Clark, A., Franklin, J., Pratt, I., & McGrice, M. A. (2010) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 6
Health-related quality of life in clinical weight loss studies
Kaukua, J. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 12
Diets, drugs, exercise, and behavioral modification: Where these work and where they do not
Kushner, R. F. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.01.008 · Cited by 5
Grosko, T. A. (2008) · Mspace (University of Manitoba) · Cited by 8
Efficacy of orlistat in type 2 diabetes: a systematic review and meta-analysis
Ghosal, S., Heron, N., Mason, K. J., & Jordan, K. P. (2025) · BJGP Open · doi:10.3399/bjgpo.2025.0058 · Cited by 5
Auti, P. S., Jagtap, U. A., & Paul, A. T. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143557 · Cited by 4
Klein, S., Fabbrini, E., & Romijn, J. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00036-5 · Cited by 9
A Review on Natural Molecules as Pancreatic Lipase Inhibitor
Joshi, J., Vala, B., Singh, S., Patel, S., & Patadiya, N. (2025) · Research Journal of Pharmacognosy and Phytochemistry · doi:10.52711/0975-4385.2025.00020 · Cited by 4
Dynamics of adipose tissue changes measured by MRI in obese patients during Reduxin treatment
Romantsova, T. I., Poluboyarinova, I. V., & Роик, О. В. (2012) · Obesity and metabolism · doi:10.14341/2071-8713-5128 · Cited by 4
Longitudinal sleeve gastrectomy: current perspectives
Basso, N., Soricelli, E., Casella, G., Rocco, G. D., & Redler, A. (2014) · Open Access Surgery · doi:10.2147/oas.s41497 · Cited by 5
Dayyeh, B. K. A., & Kaplan, L. M. (2011) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2011.02.006 · Cited by 7
Glycemic Control in the Metabolic Syndrome and Implications in Preventing Cardiovascular Disease
Gerich, J. E. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.315 · Cited by 5
Well-Being of Obese Individuals: Therapeutic Perspectives
Chaput, J., & Tremblay, A. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.243 · Cited by 5
Antiobesity drug therapy: a call for more rigorous end-point evaluation
Padwal, R. S. (2007) · Therapy · doi:10.2217/14750708.4.3.221 · Cited by 4
Self-citationDavis, S. N., & Perkins, J. M. (2007) · Endocrine Practice · doi:10.4158/ep.13.7.790 · Cited by 7
[Metabolic syndrome. Part III: its prevention and therapeutic management].
Pacholczyk, M., Ferenc, T., & Kowalski, J. (2008) · PubMed · Cited by 4
Personality and Obese Body Mass Index
Valenti, M. P., Omizo, M. M., & Mehl‐Madrona, L. (2011) · PsycEXTRA Dataset · doi:10.1037/e505232012-007 · Cited by 4
Avaliação do índice de massa corpórea em mulheres atendidas em ambulatório geral de ginecologia
Fernandes, A. M. D. S., Leme, L. C. P., Yamada, E. M., & Sollero, C. D. A. (2005) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032005000200005 · Cited by 4
Santos-Caballero, N., & Flores‐Murrieta, F. J. (2012) · Pharmacology & Pharmacy · doi:10.4236/pp.2012.33040 · Cited by 4
Nutrition in Metabolic Syndrome
Ballesteros-Pomar, M. D. (2006) · Cited by 3
A review on the current drugs and new targets for obesity
Poojashree, M. J. (2020) · Journal of Applied Pharmaceutical Research · doi:10.18231/j.joapr.2019.v.8.i.1.002 · Cited by 3
Espir, A., Abajy, M. Y., & Nayal, R. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00269 · Cited by 3
Impact of BMI Reduction After Sleeve Surgery on ESR and CRP Levels in Patients with Obesity
Farsad, F., Salimpour, S., Mirhashemi, S. H., Jolfaei, P., Erfanifar, A., Toreyhi, H., & Davoudi, Z. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07746-3 · Cited by 4
Drugs Used Clinically to Reduce Body Weight
Bray, G. A. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch24 · Cited by 5
Use of anti-obesity drugs among college students
Martins, M. D. C. D. C. E., Filho, M. D. D. S., Moura, F. S., de Carvalho, J., Müller, M., Neves, R. V., Mousinho, P. C., & Lima, I. P. (2011) · Revista da Associação Médica Brasileira · doi:10.1016/s0104-4230(11)70113-0 · Cited by 4
Dunican, K. C., Desilets, A. R., & DeBellis, R. J. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607303256 · Cited by 3
Use of orlistat in obese, dyslipidemic patients
Nelson, R. J., & Miles, J. (2006) · Future Lipidology · doi:10.2217/17460875.1.3.267 · Cited by 3
Wadden, T. A., Wolfe, B. M., Millen, B. E., Nonas, C., Pi‐Sunyer, F. X., Stevens, J., Stevens, V. J., Donato, K. A., Hu, F. B., Hubbard, S. M., et al. (2013) · Cited by 4
Clinical Management of the Metabolic Syndrome
(2007) · Springer eBooks · doi:10.1007/978-1-84628-911-8_6 · Cited by 3
Obesity and Pharmacological Treatment
Richelsen, B. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_15 · Cited by 3
McChrystal, R., Hanlon, P., Lees, J. S., Phillippo, D., Welton, N. J., Gillies, K., & McAllister, D. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111971 · Cited by 2
Lao, W., Malone, D. C., Armstrong, E., Voellinger, D. C., Somers, S. S., Jin, J., Dreyer, N. A., & GLOBE, D. R. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1059802 · Cited by 2
Tarigan, R., Kusumorini, N., & Manalu, W. (2016) · Pakistan Journal of Nutrition · doi:10.3923/pjn.2016.625.632 · Cited by 2
M, R. Y., Fernando Pimentel, M., P, D. A., N, M. G., Luis Ibáñez, A., A, E. U. D. T., Camilo Boza, W., Gersin, K. S., & Alex Escalona, P. (2010) · Revista de Cirugía · doi:10.4067/s0718-40262010000300005 · Cited by 2
Formulation and Evaluation of Transdermal Patch Containing Sibutramine
Subedi, R. K., Jang, J., Kim, J., Park, Y.-J., & Choi, H. (2010) · Journal of Korean Pharmaceutical Sciences · doi:10.4333/kps.2010.40.1.033 · Cited by 2
Es mortal, mas se puede prevenir y controlar
Cordero, R. R. Á. (2010) · Revista de la Facultad de Medicina UNAM · Cited by 2
The Role of Serotonin in Eating Behavior: Focus on 5-HT2C Receptors
Halford, J. C. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-941-3_17 · Cited by 2
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2014) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2014.20.22-35 · Cited by 2
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50032-3 · Cited by 2
Pharmacotherapy of Childhood Obesity and Pre-diabetes
Freemark, M. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_23 · Cited by 2
Halford, J. C. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-27772-6_110-2 · Cited by 2
Orlistat for the prevention of cardiovascular diseases in overweight or obese individuals
Nkansah, N., Garala, M., Agness, C. F., Davis, B. J., Ikediobi, O. N., & Bero, L. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006692 · Cited by 2
Kahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Influencing energy expenditure and substrate utilisation
Clapham, J. C., & Arch, J. R. S. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7425-9_8 · Cited by 1
Tratamiento farmacológico de la obesidad en niños
Coyote-Estrada, N., & Miranda‐Lora, A. L. (2008) · Boletín Médico del Hospital Infantil de México · Cited by 5
Rimonabant—a new hope in the treatment of obesity?
Abizaid, A. B., & Horváth, T. L. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0218 · Cited by 1
Nutrition in the metabolic syndrome: Pharmacological treatment
Ballesteros-Pomar, M. D., & León-Sanz, M. (2008) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2008.02.001 · Cited by 3
WEIGHT MAINTENANCE FOLLOWING THE COMPLETION OF A WEIGHT LOSS TRIAL: EXPLORING RACIAL DIFFERENCES
Turk, M. T. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Disease Prevention in Heart Failure
Florea, V. G., & Cohn, J. N. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10041-5 · Cited by 1
Tratamiento de la obesidad mediante una estrategia estructurada y sistematizada de autovigilancia
Acoltzin, C., Rabling, E., & Marcial, L. (2007) · Revista de la Facultad de Medicina UNAM · Cited by 1
THE COMPETITIVE EFFECTS OF DRUG WITHDRAWALS: THE CASE OF FEN-PHEN
Cawley, J., & Rizzo, J. A. (2005) · Cited by 1
Effects of Sibutramine on Insulin Resistance, Metabolic Parameters and Abdominal Fat Mass
Fenkçi, S. M., Rota, S., Sabir, N., Yaylalı, G. F., & Sermez, Y. (2007) · Turkiye Klinikleri Tip Bilimleri Dergisi · Cited by 1
Nutritional Treatment in the Metabolic Syndrome
Rubio, M. Á., Ballesteros-Pomar, M. D., & Moreno, C. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50026-7 · Cited by 1
Introduction to Diabetes and Obesity
Saad, B., Zaid, H., Shanak, S., & Kadan, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-54102-0_1 · Cited by 1
Incretin System: New Pharmacological Target in Obese Women with Polycystic Ovary Syndrome
Sever, M. J., Ferjan, S., & Janež, A. (2018) · InTech eBooks · doi:10.5772/intechopen.70648 · Cited by 1
Psychosocial Evaluation and Management of Weight Loss Surgery Patients
Shenouda, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-99774-2_12 · Cited by 1
Wharton, S., Costanian, C., Gershon, T., & Christensen, R. A. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_39 · Cited by 2
Kushner, R. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3112-3.00008-5 · Cited by 1
A case of chronic tophi gout in morbidly obese patient after laparoscopic adjustable gastric banding
Kushnarenko, N. N., Mishko, M. Y., Медведева, Т. А., & Кушнаренко, К. Е. (2020) · Obesity and metabolism · doi:10.14341/omet9736 · Cited by 1
Tarigan, R., Kusumorini, N., & Manalu, W. (2016) · Pakistan Journal of Nutrition · doi:10.3923/pjn.2016.752.759 · Cited by 1
Obesity and Diabetes: Clinical Aspects
Wharton, S., Christensen, R. A. G., Costanian, C., Gershon, T., & Rodríguez‐Saldaña, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_41 · Cited by 1
Orlistat and the Influence on Appetite Signals
Ellrichmann, M. (2011) · Springer eBooks · doi:10.1007/978-0-387-92271-3_86 · Cited by 1
Obesity and Therapeutic Approaches to Weight Loss
Kushner, R. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-963-5_4 · Cited by 1
Barros, L. T. D. C. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2006.tde-19012007-145650 · Cited by 1
Metadata
- Authors
- Padwal, R., Li, S. K., & Lau, D. C. W.
- Affiliations
- University of Alberta Hospital (CA)
- University of Calgary (CA)
- Corresponding author
- Padwal, R
- ORCID
- Venue
- International Journal of Obesity
- Published
- 2003-09-16
- Volume
- 27
- Issue
- 12
- Pages
- 1437-1446
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2135749311
- Cited by
- 348
- References
- 57
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 21 · 2012: 20
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- anti-obesity drugs, orlistat, sibutramine, obesity, overweight, weight loss, long-term efficacy, drug safety, gastrointestinal adverse effects, blood pressure, cardiovascular risk
- MeSH terms
- Orlistat, Cyclobutanes, Humans, Lactones, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.